As ARID5B SNPs are closely correlated to the onset and outcome of childhood ALL, the published findings warrant extensive genetic and functional studies to unravel the molecular mechanisms and evaluate the diagnostic and therapeutic significance of ARID5B for ALL. This evidence concerns the gene ARID5B and acute lymphoblastic leukemia.